Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
International Journal of Physiology and Pathophysiology
SJR: 0.116

ISSN Печать: 2155-014X
ISSN Онлайн: 2155-0158

Archives: Volume 1, 2010 to Volume 9, 2018

International Journal of Physiology and Pathophysiology

DOI: 10.1615/IntJPhysPathophys.v5.i2.80
pages 171-182

Mesenchymal Stem Cells and Their Immune Properties

Mykola I. Lisianyi
Romodanov Institute of Neurosurgery, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine

Краткое описание

Mesenchymal stem cells (MSC) are available in various body tissues, including bone marrow, adipose tissue, and skin. They can multiply not only at in vivo conditions, but also in vitro. MSCs have great regenerative potential, and they are able to proliferate into different types of tissues. Moreover, MSCs exhibit pronounced immunosuppressive properties and can inhibit the functioning of various immune cells, especially T-lymphocytes, killer and dendritic cells. These properties have being used in clinical applications to inhibit autoimmune responses and bone marrow rejection reactions. It has been shown that MSC immunosuppression is achieved through the synthesis of humoral factors such as cytokines, indolamino-2,3-dioxygenase (IDO), nitric oxide, human leucocyte antigen G (HLA-G), interleukines. In case of using MSCs to treat myocardial infarction in rats, these cells are transformed into myocytes, they change their antigenic profile, losing the ability to inhibit immune responses, which leads to rejection. These facts are important to elucidate the mechanism of their action and use in clinical practice for both immunosuppression and stem cell therapy.


Articles with similar content:

Potential Role of Induced Pluripotent Stem Cells as Regenerative Medicine in Retinal Cell Damage
Journal of Environmental Pathology, Toxicology and Oncology, Vol.37, 2018, issue 4
Yi-Ran Pan, Ying-Jian Sun, Bin Fan, Guang-Yu Li
Cytokines in Immunity and Allograft Rejection
Critical Reviews™ in Immunology, Vol.22, 2002, issue 4
Joren C. Madsen, James S. Allan, Louis C. Benjamin, III
Immunomodulation of Experimental Autoimmune Diseases via Oral Tolerance
Critical Reviews™ in Immunology, Vol.20, 2000, issue 1
Yehuda Shoenfeld, Ilan Krause, Miri Blank
Immunomodulatory Activities of Mushroom Glucans and Polysaccharide–Protein Complexes in Animals and Humans (A Review)
International Journal of Medicinal Mushrooms, Vol.5, 2003, issue 2
Richard Sullivan, John E. Smith, Neil J. Rowan
Interleukin 35−Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases
Critical Reviews™ in Immunology, Vol.35, 2015, issue 1
Charles E. Egwuagu, Cheng-Rong Yu